Emilly S Villodre - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Neuro-Oncology|January 23, 2026

Soluble E-cadherin-CXCL1-CXCR2 Axis as a Therapeutic Vulnerability in Inflammatory Breast Cancer Brain MetastasisXiaoding Hu, Yun Xiong, Emilly S Villodre, et al.

Journal of the National Cancer Institute|December 11, 2021

NDRG1 in Aggressive Breast Cancer Progression and Brain MetastasisEmilly S Villodre, Xiaoding Hu, Bedrich L Eckhardt, et al.

Molecular Oncology|August 3, 2021

Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasionEmilly S Villodre, Xiaoding Hu, Richard Larson, et al.

Molecular Cancer Therapeutics|May 13, 2025

Inhibition of MCL-1 and MEK overcomes MEK inhibitor resistance in triple-negative and inflammatory breast cancersMohd Mughees, Moises J Tacam, Alex W Tan, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Neuro-Oncology|January 23, 2026

Soluble E-cadherin-CXCL1-CXCR2 Axis as a Therapeutic Vulnerability in Inflammatory Breast Cancer Brain MetastasisXiaoding Hu, Yun Xiong, Emilly S Villodre, et al.

Journal of the National Cancer Institute|December 11, 2021

NDRG1 in Aggressive Breast Cancer Progression and Brain MetastasisEmilly S Villodre, Xiaoding Hu, Bedrich L Eckhardt, et al.

Molecular Oncology|August 3, 2021

Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasionEmilly S Villodre, Xiaoding Hu, Richard Larson, et al.

Molecular Cancer Therapeutics|May 13, 2025

Inhibition of MCL-1 and MEK overcomes MEK inhibitor resistance in triple-negative and inflammatory breast cancersMohd Mughees, Moises J Tacam, Alex W Tan, et al.

Pageof 2